EdgeRx Review: Men's-Only, With a Named Advisor and a Bundled NAD+ Price

The one-sentence version

EdgeRx is explicit about who it is for — "PRESCRIPTION PROTOCOLS FOR MEN" — and, within that limitation, publishes more than most unmonetized rows we grade: a named Chief Medical Advisor, a 503A compounding claim on its own FAQ, and an "Energy, Longevity & Cognition" tier priced from $99/month. The catch is what that tier actually contains — NAD+ bundled with glutathione, not NAD+ alone — and who it excludes by design. It grades B, 8 points out of 14, computed from published terms alone.

What it is, and who it's for

EdgeRx's homepage states its positioning without hedging: prescription peptide and longevity protocols built for men. Its catalogue splits into five priced tiers rather than individual product pages. The one this board ranks on, "Energy, Longevity & Cognition," bundles NAD+ and glutathione protocols from $99/month. Sermorelin sits in a separate tier, "Recovery & Vitality," from $199/month, and GHK-Cu sits in a third, "Skin, Hair & Aesthetics," at a flat $199/month. No tier publishes a price for a single product in isolation.

If you are a man comparison-shopping longevity peptides and you value a named medical advisor, EdgeRx is a real option. If you are not a man, or you want a standalone NAD+ price rather than a bundled tier, this is not built for you — and that is stated on the site, not something we inferred.

What it actually costs

Verified live on edgerx.org and its FAQ, 4 August 2026. "Energy, Longevity & Cognition" (NAD+ + glutathione): from $99/month. "Recovery & Vitality" (sermorelin): from $199/month. "Skin, Hair & Aesthetics" (GHK-Cu): $199/month flat. No individual figure exists for NAD+ on its own — the $99 floor is the tier's entry price, covering two protocols together, not one.

Our rubric asks for one all-in figure a reader can act on before committing. EdgeRx's $99 clears the bar as a real, published number with no quiz gate — but because it prices a bundle rather than a single product, and because the site does not break out what NAD+ alone would cost inside that bundle, we score this the same way we score any tier-floor pricing on this board: it earns credit for being published, and its ambiguity is named plainly in the cons rather than smoothed over.

Clinical oversight and the pharmacy

EdgeRx's own FAQ states plainly: "A board-certified US physician reviews your history and, if a protocol is appropriate, prescribes it" — with no separate consultation charge disclosed anywhere we found, unlike CeliaRx, which bills a $55 consult apart from its product prices. That absence of a stated extra fee, combined with the review being a required step to get any protocol at all, is why this row scores the consult factor as included.

On compounding, the same FAQ states: "All are compounded by a 503A pharmacy, where your prescription is made specifically for you, with one exception: MICC is prepared by an FDA-registered 503B outsourcing facility." That is a 503A claim published on a page EdgeRx controls, which clears the top rung of our pharmacy test — though, on our own re-check, the facility itself is not named on that page. Named Chief Medical Advisor Dr. John Starke, MD (ABEM board-certified) does not personally prescribe; the actual prescribing pool is unnamed board-certified physicians. States served: 46, excluding Arkansas, Indiana, Minnesota and South Carolina, confirmed on the same FAQ.

The evidence behind what it sells

EdgeRx's tier name is the most direct cognition-adjacent claim on this board's unmonetized field — "Energy, Longevity & Cognition" — and it is worth being precise about what that buys. The 2026 PRISMA-guided systematic review of NAD+ found effects on functional, metabolic and vascular outcomes "heterogeneous and often null or endpoint-specific," with clinical effectiveness inconclusive¹; no completed human trial in that review showed a cognition-specific benefit. For GHK-Cu, the peptide sold under EdgeRx's Skin, Hair & Aesthetics tier, the mechanistic and preclinical case for tissue repair and gene-expression effects is genuinely stronger than most peptides sold here, though human outcome trials remain limited². For sermorelin, the trial testing this exact nightly-injection protocol in older men raised nocturnal growth hormone but produced no change in IGF-1 and no change in DEXA-measured muscle or fat³. See NAD+ for longevity and peptides for longevity.

Where it's weak, and who should skip it

Skip it outright if you are not a man — the site says so itself. Skip it if you want a standalone NAD+ price, because $99 buys NAD+ bundled with glutathione, not NAD+ alone, and no per-product figure is published. If you proceed, confirm which of the 46 served states you're in and ask what NAD+ alone would cost split out of the bundle.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). EdgeRx takes zero on price transparency, because the $99 floor prices a bundle rather than a single product with no per-item figure published; the full four for a genuine longevity/peptide line across three tiers; two for a physician review that is required and not billed separately; and two for its own-site 503A claim. Human support is not stated as included, so it scores zero there too. Eight of fourteen: a B. Two neighbours added the same day are our CeliaRx review and Nolu review; the full field is at our provider rankings.